← Open Payments lookup

BRIAN KENNEDY: Open Payments

NPI 1952958837 · GILBERT, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$352 in 14 payments from 8 companies in 2025. Trend: 2023 $913 · 2024 $945 · 2025 $352

Food & beverage: $352
CompanyPaymentsAmount
Novo Nordisk Inc6$199
GlaxoSmithKline, LLC.2$41
Lilly USA, LLC1$21
PFIZER INC.1$20
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$19
ABBVIE INC.1$19
AstraZeneca Pharmaceuticals LP1$18
Vanda Pharmaceuticals Inc.1$16

Products named: Ozempic, Rybelsus, TRELEGY ELLIPTA, MOUNJARO, PAXLOVID, CAPLYTA, VRAYLAR, AIRSUPRA.

Industry payments across AZ — which companies pay providers there.